Insmed (INSM) Asset Utilization Ratio (2011 - 2026)

Insmed (INSM) recorded quarterly Asset Utilization Ratio of 0.38 in Q1 2026, up 44.02% quarter-over-quarter from 0.26 in Q4 2025, and up 89.7% on a YoY basis from 0.2 in Q1 2025.

Insmed (INSM) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Insmed's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.38 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio rose 89.7% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 0.38 (up 89.7% YoY), while the FY2025 annual figure was 0.28, up 30.4% from the prior year.
  • Asset Utilization Ratio was 0.38 for Q1 2026 at Insmed, up from 0.26 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.38 in Q1 2026 to a low of 0.16 in Q1 2023.
  • Historically, Asset Utilization Ratio has averaged 0.21 across 5 years, with a median of 0.2 in 2025.
  • The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio declined 25.46% in 2022, then jumped 89.7% in 2026.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.19 in 2022, then increased by 24.23% to 0.23 in 2023, then dropped by 22.43% to 0.18 in 2024, then soared by 47.01% to 0.26 in 2025, then surged by 44.02% to 0.38 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.38 (Q1 2026), 0.26 (Q4 2025), and 0.18 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 0.55
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.60
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 1,422.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 0.47
9 Abivax 91.71 Bn 91.71 Bn - -
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn 0.38

Historic Data

Download Data
DateValue
Mar 31, 2026 0.38
Dec 31, 2025 0.26
Sep 30, 2025 0.18
Jun 30, 2025 0.19
Mar 31, 2025 0.20
Dec 31, 2024 0.18
Sep 30, 2024 0.18
Jun 30, 2024 0.22
Mar 31, 2024 0.25
Dec 31, 2023 0.23
Sep 30, 2023 0.20
Jun 30, 2023 0.18
Mar 31, 2023 0.16
Dec 31, 2022 0.19
Sep 30, 2022 0.24
Jun 30, 2022 0.20
Mar 31, 2022 0.17
Dec 31, 2021 0.15
Sep 30, 2021 0.14
Jun 30, 2021 0.18